Results 211 to 220 of about 510,536 (231)

SARS-CoV-2 nsp15 enhances viral virulence by subverting host antiviral defenses. [PDF]

Proc Natl Acad Sci U S A
Caobi A, Su CM, Beusch CM, Kenney D, Darling TL, Feng S, Semaan M, Wacquiez A, Sanders NL, Tully ES, Chen DY, Evdokimova M, Ding Z, Jones D, Alysandratos KD, Mizgerd JP, Kirchdoerfer RN, Kotton DN, Douam F, Crossland NA, Boon ACM, Gordon DE, Baker SC, Saeed M.   +23 more
europepmc   +1 more source

Analysing genome sequences and associated metadata during the COVID-19 pandemic in Iraq revealed points to be improved: An observational retrospective study. [PDF]

PLoS One
Abbas AH, Al-Zebeeby A, Al-Saadi M, Neamah AJ.   +3 more
europepmc   +1 more source

Diammonium Glycyrrhizinate Exerts Broad-Spectrum Antiviral Activity Against Human Coronaviruses by Interrupting Spike-Mediated Cellular Entry. [PDF]

Int J Mol Sci
Wu S, Yang G, Wang K, Yan H, Wang H, Li X, Qiao L, Wu M, Wang Y, Jiang JD, Li Y.   +10 more
europepmc   +1 more source

Host protein ARF1 is a proviral factor for SARS-CoV-2 and a candidate broad-spectrum therapeutic target. [PDF]

Nat Commun
Zhang C, Min YQ, Xue H, Zhang H, Liu K, Tian Y, Yang Z, Zhao Z, Yang H, Shan C, Sun X, Ning YJ.   +11 more
europepmc   +1 more source

A longitudinal assessment of the antibody response to SARS-CoV-2 infection in the New Mexican population. [PDF]

PLoS One
Twohig FM, Baranowski TM, Ye C, Harkins M, Bradfute SB.   +4 more
europepmc   +1 more source

Computable phenotypes to identify respiratory viral infections in the All of Us research program. [PDF]

Sci Rep
Waxse BJ, Bustos Carrillo FA, Tran TC, Mo H, Ricotta EE, Denny JC.   +5 more
europepmc   +1 more source

The Recurring Loss of ORF8 Secretion in Dominant SARS-CoV-2 Variants. [PDF]

Int J Mol Sci
Lam JY, Kok KH.
europepmc   +1 more source

Insurance and Epidemics: SARS, West Nile Virus and Nipah Virus [PDF]

Journal of Insurance Medicine, 2021
Severe acute respiratory syndrome (SARS) reminds us that sudden disease emergence is a permanent part of our world—and should be anticipated in our planning. Historically the emergence of new diseases has had little or no impact beyond a small, localized cluster of infections.
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Asthma in the era of SARS CoV-2 virus

Journal of Asthma, 2021
It is well established in international literature that respiratory viruses can trigger asthma exacerbations. However, not all viruses affect patients in the same manner and extent. The pandemic of the SARS CoV-2 virus has brought interest to study the association of this novel virus on patients with mild-moderate and severe asthma in terms of ...
Agamemnon Bakakos, Anastasia Krompa
openaire   +3 more sources

SARS: Understanding the Virus and Development of Rational Therapy

Current Molecular Medicine, 2005
In late 2002 a new disease, severe atypical respiratory syndrome (SARS), emerged in China. A hitherto unknown animal coronavirus (CoV) that had crossed the species barrier through close contact of humans with infected animals was identified as the etiological agent.
K Stadler, R Rappuoli
openaire   +3 more sources